These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 29634187)

  • 1. Non-Conjugated Chitosan-Based Nanoparticles to Proteic Antigens Elicit Similar Humoral Immune Responses to Those Obtained with Alum.
    Izaguirre-Hernández IY; Mellado-Sánchez G; Mondragón-Vásquez K; Thomas-Dupont P; Sánchez-Vargas LA; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Hernández-Flores KG; Mendoza-Barrera C; Altuzar V; Cedillo-Barrón L; Vivanco-Cid H
    J Nanosci Nanotechnol; 2017 Jan; 17(1):846-52. PubMed ID: 29634187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugation of protein antigen to microparticulate beta-glucan from Saccharomyces cerevisiae: a new adjuvant for intradermal and oral immunizations.
    Berner VK; Sura ME; Hunter KW
    Appl Microbiol Biotechnol; 2008 Oct; 80(6):1053-61. PubMed ID: 18677470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response.
    Pawar D; Jaganathan KS
    Drug Deliv; 2016; 23(1):185-94. PubMed ID: 24825494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced immune response against pertussis toxoid by IgA-loaded chitosan-dextran sulfate nanoparticles.
    Sharma S; Mukkur TK; Benson HA; Chen Y
    J Pharm Sci; 2012 Jan; 101(1):233-44. PubMed ID: 21953499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OVA-bound nanoparticles induce OVA-specific IgG1, IgG2a, and IgG2b responses with low IgE synthesis.
    Yanase N; Toyota H; Hata K; Yagyu S; Seki T; Harada M; Kato Y; Mizuguchi J
    Vaccine; 2014 Oct; 32(45):5918-24. PubMed ID: 25211769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model.
    Khorshidvand Z; Khosravi A; Mahboobian MM; Larki-Harchegani A; Fallah M; Maghsood AH
    Int J Biol Macromol; 2022 May; 208():962-972. PubMed ID: 35346684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK; Tomar P; Sharma V; Dixit VK
    Vaccine; 2011 Nov; 29(48):9026-37. PubMed ID: 21939718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of chitosan and aluminium as a new adjuvant strategy for improved vaccination.
    Lebre F; Bento D; Ribeiro J; Colaço M; Borchard G; de Lima MCP; Borges O
    Int J Pharm; 2017 Jul; 527(1-2):103-114. PubMed ID: 28522427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of nanoparticle adjuvants to potentiate the immune response against diphtheria toxoid.
    Alshanqiti FM; Al-Masaudi SB; Al-Hejin AM; El-Baky NA; Redwan EM
    Hum Antibodies; 2018 Feb; 26(2):75-85. PubMed ID: 29171990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.
    Skrastina D; Petrovskis I; Lieknina I; Bogans J; Renhofa R; Ose V; Dishlers A; Dekhtyar Y; Pumpens P
    PLoS One; 2014; 9(12):e114006. PubMed ID: 25436773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
    Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X; Liu N; Wang Z; Gao J; Zhang H; Li M; Du Y; Gao X; Zheng A
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
    Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G
    Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycation-decorated PLA microspheres induce robust immune responses via commonly used parenteral administration routes.
    Chen X; Wang L; Liu Q; Jia J; Liu Y; Zhang W; Ma G; Su Z
    Int Immunopharmacol; 2014 Dec; 23(2):592-602. PubMed ID: 25466267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poly-ϵ-caprolactone/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen.
    Jesus S; Soares E; Borchard G; Borges O
    Nanomedicine (Lond); 2017 Oct; 12(19):2335-2348. PubMed ID: 28868964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
    Tafaghodi M; Saluja V; Kersten GF; Kraan H; Slütter B; Amorij JP; Jiskoot W
    Vaccine; 2012 Aug; 30(36):5341-8. PubMed ID: 22749834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens.
    Mutwiri G; Benjamin P; Soita H; Townsend H; Yost R; Roberts B; Andrianov AK; Babiuk LA
    Vaccine; 2007 Jan; 25(7):1204-13. PubMed ID: 17140708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acidified sucralfate encapsulated chitosan derivative nanoparticles as oral vaccine adjuvant delivery enhancing mucosal and systemic immunity.
    Zhao Z; Qiao S; Jin Z; Li H; Yu H; Zhang C; Yin TH; Zhao K
    Int J Biol Macromol; 2024 Nov; 279(Pt 3):135424. PubMed ID: 39245128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
    Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.